IP Library Patent Application 18414225
Patent Application
App. No. 18/414,225

METHODS FOR EXPANDING HEMATOPOIETIC STEM CELLS USING REVITALIZED MESENCHYMAL STEM CELLS

Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US None
App. No.
18/414,225
Abstract

A method for revitalizing mesenchymal stem cells (MSC) maintained in culture by transducing the MSC with vectors encoding a specific gene combination, as well as methods of use of MSC so revitalized in co-culturing hematopoictic stem cells.

Claims (15)

1 - 39 . (canceled)

40 . A method for preparing a revitalized mesenchymal stem cell (MSC) comprising:

culturing a mesenchymal stem cell (MSC); and

transducing the MSC with one or more vector(s), the vector(s) encoding at least one of the following genes: Ostf1 (osteoclast stimulating factor 1), Xbp1 (X-box binding protein 1), Irf3 (interferon regulatory factor 1), and Irf7 (interferon regulatory factor 7) under conditions permitting expression of the genes.

41 . The method of claim 40 , wherein the vector(s) further encode the gene Klf7 (Kruppel-like factor 7).

42 . The method of claim 40 , wherein each gene is encoded by a different vector.

43 . The method of claim 40 , wherein two or more genes are encoded by the same vector.

44 . The method of claim 41 , wherein Ostf1, Xbp1, Irf3, and Irf7 are encoded by a single vector.

45 . The method of claim 40 , further comprising co-culturing a hematopoietic stem cell (HSC) with the MSC.

46 . The method of claim 40 , wherein the MSC is bone-marrow derived, cord-blood derived, or adipose-tissue derived.

47 . The method of claim 45 , wherein the HSC is bone-marrow derived, cord-blood derived, or adipose-tissue derived.

48 . The method of claim 45 , wherein the HSC and the MSC are obtained from a subject.

49 . The method of claim 45 , wherein the MSC is pretreated with one or more vector(s), the vector(s) encoding the following genes: Ostf1, Xbp1, Irf3, and Irf7 under conditions permitting expression of the genes, and adding an amount of HSC to the MSC in culture, so as to co-culture the HSC and MSC.

50 . The method of claim 49 , wherein the vector(s) further encode the gene Klf7.

51 . The method of claim 40 , further comprising co-culturing a leukemic stem cell (LSC) with the MSC.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 17, 2024
From: FRENETTE, PAUL S.; NAKAHARA, FUMIO
To: ALBERT EINSTEIN COLLEGE OF MEDICINE, INC.
Reel/Frame 067140/0178 →
MERGER Recorded Apr 17, 2024
From: ALBERT EINSTEIN COLLEGE OF MEDICINE, INC.
To: ALBERT EINSTEIN COLLEGE OF MEDICINE
Reel/Frame 067140/0258 →